help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rechler, M. M.
Right arrow Articles by Humbel, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rechler, M. M.
Right arrow Articles by Humbel, R. E.

Endocrinology, Vol 107, 1451-1459, Copyright © 1980 by Endocrine Society


ARTICLES

Interactions of insulin-like growth factors I and II and multiplication- stimulating activity with receptors and serum carrier proteins

MM Rechler, J Zapf, SP Nissley, ER Froesch, AC Moses, JM Podskalny, EE Schilling and RE Humbel

Insulin-like growth factors (IGFs) I and II, purified from human plasma, and multiplication-stimulating activity (MSA), purified from media conditioned by the BRL 3A rat liver cell line, are polypeptides with similar biological and biochemical properties. We have compared the interaction of 125I-labeled and unlabeled MSA, IGF-I, and IGF-II with four intact cell or cell membrane preparations previously shown to possess MSA receptors: rat liver plasma membranes, chick embryo fibroblasts, human fibroblasts, and BRL 3A2 cells. In each case, specific binding of 125I-labeled IGF-I and IGF-II was demonstrated. With each 125I-labeled peptide, significant inhibition of binding and parallel dose-response curves were observed with unlabeled IGF-I, IGF- II, and MSA. Striking differences were noted, however, in the relative potencies of the unlabeled peptides as competitive inhibitors of binding. We conclude that the different specificities of binding inhibition reflect a significant heterogeneity among IGF receptors. A similar heterogeneity appears to occur among somatomedin carrier proteins in rat and human sera.


This article has been cited by other articles:


Home page
EndocrinologyHome page
B. G. Irani, A. A. Dunn-Meynell, and B. E. Levin
Altered Hypothalamic Leptin, Insulin, and Melanocortin Binding Associated with Moderate-Fat Diet and Predisposition to Obesity
Endocrinology, January 1, 2007; 148(1): 310 - 316.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Sakai, H. B. Lowman, and D. R. Clemmons
Increases in Free, Unbound Insulin-like Growth Factor I Enhance Insulin Responsiveness in Human Hepatoma G2 Cells in Culture
J. Biol. Chem., April 12, 2002; 277(16): 13620 - 13627.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. A. Hill, A. Tumber, and M. C. Meikle
Multiple Extracellular Signals Promote Osteoblast Survival and Apoptosis
Endocrinology, September 1, 1997; 138(9): 3849 - 3858.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. C. Groskopf, L.-J. Syu, A. R. Saltiel, and D. I. H. Linzer
Proliferin Induces Endothelial Cell Chemotaxis through a G Protein-Coupled, Mitogen-Activated Protein Kinase-Dependent Pathway
Endocrinology, July 1, 1997; 138(7): 2835 - 2840.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1980 by The Endocrine Society